Found: 2
Select item for more details and to access through your institution.
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 6, p. 2710, doi. 10.1007/s12325-022-02384-y
- By:
- Publication type:
- Article
Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO).
- Published in:
- Nefrologia, 2022, v. 42, n. 3, p. 301, doi. 10.1016/j.nefroe.2022.05.005
- By:
- Publication type:
- Article